|
- An example of the deleterious effect of anemia on survival in patients with congestive heart failure is noted here. Chronic Kidney Disease (CKD) is a frequent cause of anemia in these patients. As hemoglobin decreases (horizontal axis), 1-year mortality risk increases (vertical axis):
The following is from the National Kidney Foundation's Guidelines for the care of patients with chronic kidney disease (KDOQI).
Clinical Practice Guidelines
Guideline Development and Methodology
Disclaimer and Acceptable Use Policy
Guiding Principles for Corporate Relationships (PDF* 27 KB)
Published KDOQI Guidelines
- Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
Primary Sponsor: Satellite Healthcare
Implementation Sponsor: Genzyme
Amgen is the Founding and Principal Sponsor of KDOQI
- Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
American Journal of Kidney Diseases, May 2004
Primary Sponsor: Astra Zeneca
Implementation Sponsor: Merck & Co., Inc
Amgen is the Founding and Principal Sponsor of KDOQI
- Bone Metabolism and Disease in Chronic Kidney Disease
American Journal of Kidney Diseases, October 2004
Primary Sponsor: Abbott Laboratories
Associate Sponsors: Amgen, Genzyme
Implementation Sponsors: Abbott Laboratories, Amgen, Bone Care International, Genzyme, Shire US
Amgen is the Founding and Principal Sponsor of KDOQI
- Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation Classification and Stratification
American Journal of Kidney Diseases, February 2002
Primary Sponsor: Amgen
Implementation Sponsors: Bayer Diagnostics, OrthoBiotech Products, LP, UpToDate
Amgen is the Founding and Principal Sponsor of KDOQI
- Managing Dyslipidemias in Chronic Kidney Disease
American Journal of Kidney Diseases, April 2003
Primary Sponsor: Fujisawa
Amgen is the Founding and Principal Sponsor of KDOQI
- Clinical Practice Guidelines for Managing Dyslipidemias in Kidney Transplant Patients
Am J Trans 2004:4 (Suppl. 7)
Primary Sponsor: Fujisawa
Amgen is the Founding and Principal Sponsor of KDOQI
- Hemodialysis Adequacy Update
American Journal of Kidney Diseases, January 2001
Primary Sponsor: Amgen
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
Amgen is the Founding and Principal Sponsor of KDOQI
- Peritoneal Dialysis Adequacy Update
American Journal of Kidney Diseases, January 2001
Primary Sponsor: Amgen
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
Amgen is the Founding and Principal Sponsor of KDOQI
- Treatment of Anemia of Chronic Renal Failure Update
American Journal of Kidney Diseases, January 2001
Primary Sponsor: Amgen
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
Amgen is the Founding and Principal Sponsor of KDOQI
- Vascular Access Update
American Journal of Kidney Diseases, January 2001
Primary Sponsor: Amgen
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
Amgen is the Founding and Principal Sponsor of KDOQI
- Nutrition in Chronic Renal Failure
American Journal of Kidney Diseases, June 2000
Primary Sponsor: Sigma Tau
Sponsor: Baxter Healthcare, Fresenius USA
Associate Sponsor: Luitpold Pharmaceuticals (American Regent)
Implementation Sponsor: Watson Pharmaceuticals
Amgen is the Founding and Principal Sponsor of KDOQI
Guidelines Under Development
|
|
|
